[go: up one dir, main page]

WO2000073421A3 - Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells - Google Patents

Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells Download PDF

Info

Publication number
WO2000073421A3
WO2000073421A3 PCT/US2000/040052 US0040052W WO0073421A3 WO 2000073421 A3 WO2000073421 A3 WO 2000073421A3 US 0040052 W US0040052 W US 0040052W WO 0073421 A3 WO0073421 A3 WO 0073421A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
epithelial cells
human amniotic
cryopreservation
amniotic epithelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/040052
Other languages
French (fr)
Other versions
WO2000073421A2 (en
Inventor
Valerie W Hu
Allan L Goldstein
Gordon Wigginton
Peter D Prestidge
Jonathan M Sackier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LIFEBANK SERVICES LLC
Original Assignee
LIFEBANK SERVICES LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIFEBANK SERVICES LLC filed Critical LIFEBANK SERVICES LLC
Priority to AU48609/00A priority Critical patent/AU4860900A/en
Publication of WO2000073421A2 publication Critical patent/WO2000073421A2/en
Publication of WO2000073421A3 publication Critical patent/WO2000073421A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Dentistry (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention is directed to human amniotic epithelial cells derived from placenta at delivery, and the methods for isolating, culturing, and cryopreserving them for future therapeutic uses. Additionally, the present invention is directed to methods for inducing differentiation of these multipotentials cells, for assaying the cell types derived, and for manipulating the cells by gene transfection and other means for therapeutic applications, icluding but not limited to enzyme replacement and gene therapy, tissue regeneration and replacement, as well as burn and wound dressings.
PCT/US2000/040052 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells Ceased WO2000073421A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU48609/00A AU4860900A (en) 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13774099P 1999-06-02 1999-06-02
US60/137,740 1999-06-02

Publications (2)

Publication Number Publication Date
WO2000073421A2 WO2000073421A2 (en) 2000-12-07
WO2000073421A3 true WO2000073421A3 (en) 2001-04-26

Family

ID=22478856

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/040052 Ceased WO2000073421A2 (en) 1999-06-02 2000-06-01 Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells

Country Status (2)

Country Link
AU (1) AU4860900A (en)
WO (1) WO2000073421A2 (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7255879B2 (en) 2000-12-06 2007-08-14 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US7413734B2 (en) 2003-06-27 2008-08-19 Ethicon, Incorporated Treatment of retinitis pigmentosa with human umbilical cord cells
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US7875273B2 (en) 2004-12-23 2011-01-25 Ethicon, Incorporated Treatment of Parkinson's disease and related disorders using postpartum derived cells
US7976836B2 (en) 2000-12-06 2011-07-12 Anthrogenesis Corporation Treatment of stroke using placental stem cells
US8067233B2 (en) 2004-02-26 2011-11-29 Reliance Life Science Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
US8187875B2 (en) 2004-02-26 2012-05-29 Reliance Life Sciences Pvt. Ltd. Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof
US8460650B2 (en) 2007-02-12 2013-06-11 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
US8617535B2 (en) 2002-11-26 2013-12-31 Anthrogenesis Corporation Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US8691217B2 (en) 2005-12-29 2014-04-08 Anthrogenesis Corporation Placental stem cell populations
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US8895256B2 (en) 2005-10-13 2014-11-25 Anthrogenesis Corporation Immunomodulation using placental stem cells
US8926964B2 (en) 2010-07-13 2015-01-06 Anthrogenesis Corporation Methods of generating natural killer cells
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
US9121007B2 (en) 2010-01-26 2015-09-01 Anthrogenesis Corporatin Treatment of bone-related cancers using placental stem cells
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US9175261B2 (en) 2005-12-16 2015-11-03 DePuy Synthes Products, Inc. Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
US9198938B2 (en) 2008-11-19 2015-12-01 Antrhogenesis Corporation Amnion derived adherent cells
US9216200B2 (en) 2007-09-28 2015-12-22 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
US9234172B2 (en) 2003-06-27 2016-01-12 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells
US9254302B2 (en) 2010-04-07 2016-02-09 Anthrogenesis Corporation Angiogenesis using placental stem cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US9598669B2 (en) 2005-12-29 2017-03-21 Anthrogenesis Corporation Composition for collecting placental stem cells and methods of using the composition

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1004204B (en) * 1999-09-29 2003-09-05 Cryopreserved amniotic human cells for future therapeutic, diagnostic, genetic and other uses
US7118845B2 (en) 2000-06-15 2006-10-10 3M Innovative Properties Company Multiphoton photochemical process and articles preparable thereby
EP3246396B1 (en) 2001-02-14 2020-01-29 Celularity, Inc. Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells
WO2003042405A2 (en) 2001-11-15 2003-05-22 Children's Medical Center Corporation Methods of isolation, expansion and differentiation of fetal stem cells from chorionic villus, amniotic fluid, and placenta and therapeutic uses thereof
WO2003047607A1 (en) * 2001-12-06 2003-06-12 Sankyo Company, Limited Medicinal compositions containing human amnion-origin cells
EP2301343A1 (en) 2002-02-13 2011-03-30 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells
US8062837B2 (en) 2002-02-14 2011-11-22 Stemcyte, Inc. Plasma-depleted, not erythrocyte-depleted, cord blood compositions and method of making
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
EP1497435A4 (en) * 2002-04-19 2005-07-27 Univ Pittsburgh PLACENTAL STEM CELLS AND USES
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
AU2003254298A1 (en) 2002-08-02 2004-02-23 Stratatech Corporation Species specific dna detection
ATE510005T1 (en) 2003-06-27 2011-06-15 Univ Laval METHOD FOR ISOLATION OF CELLS FROM THE UMBILE CORD
JP2006006249A (en) * 2004-06-28 2006-01-12 Hiroshima Univ Method for culturing amnion-derived cells and use thereof
BRPI0514387B8 (en) 2004-08-16 2021-05-25 Cellresearch Corp Pte Ltd method to isolate epithelial or mesenchymal/progenitor stem cells from the amniotic membrane of the umbilical cord, in vitro method for culturing mesenchymal/progenitor stem cells, pharmaceutical composition and use of an epithelial or mesenchymal/progenitor stem cell
US20060222634A1 (en) 2005-03-31 2006-10-05 Clarke Diana L Amnion-derived cell compositions, methods of making and uses thereof
US8153430B2 (en) 2005-03-31 2012-04-10 Stemnion, Inc. Methods related to surgery
US8048619B2 (en) 2005-06-02 2011-11-01 Stemcyte, Inc. Method of treating a hematopoietic associated disease or disorder with plasma-depleted, but not erythrocyte-depleted cord blood compositions
US8287854B2 (en) 2005-10-21 2012-10-16 Cellresearch Corporation Pte Ltd Skin equivalents derived from umbilical cord mesenchymal stem/progenitor cells and umbilical cord epithelial stem/progenitor cells
EP2412801A1 (en) 2005-12-29 2012-02-01 Anthrogenesis Corporation Co-Culture of placental stem cells and stem cells from a second source
US8871198B2 (en) 2006-03-29 2014-10-28 Stemnion, Inc. Methods related to wound healing
CN101432031A (en) 2006-02-24 2009-05-13 利莱恩斯生命科学有限公司 Conjunctival tissue system
WO2007108003A2 (en) 2006-03-23 2007-09-27 Pluristem Ltd. Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
US8980630B2 (en) * 2006-06-28 2015-03-17 Rutgers, The State University Of New Jersey Obtaining multipotent amnion-derived stem cell (ADSC) from amniotic membrane tissue without enzymatic digestion
US8221741B2 (en) 2007-01-17 2012-07-17 Marshall Vivienne S Methods for modulating inflammatory and/or immune responses
WO2008100497A1 (en) 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
WO2009008928A2 (en) 2007-04-13 2009-01-15 Stemnion, Inc. Methods for treating nervous system injury and disease
WO2008144820A1 (en) * 2007-05-28 2008-12-04 Monash University Treatment of chronic lung disease
WO2008156659A1 (en) * 2007-06-18 2008-12-24 Children's Hospital & Research Center At Oakland Method of isolating stem and progenitor cells from placenta
AU2008325142A1 (en) 2007-11-07 2009-05-14 Anthrogenesis Corporation Use of umbilical cord blood in the treatment of premature birth complications
ES2612469T3 (en) 2008-08-20 2017-05-17 Anthrogenesis Corporation Improved cell composition and methods of making it
US10179900B2 (en) 2008-12-19 2019-01-15 DePuy Synthes Products, Inc. Conditioned media and methods of making a conditioned media
CN107028983A (en) 2008-12-19 2017-08-11 德普伊新特斯产品有限责任公司 The treatment of PUD D and illness
WO2010111663A1 (en) 2009-03-26 2010-09-30 Ethicon, Inc. Human umbilical cord tissue cells as therapy for alzheimer' s disease
US8647617B2 (en) 2009-07-13 2014-02-11 Stemnion, Inc. Methods for modulating inflammatory and/or immune responses
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8840665B2 (en) 2010-06-11 2014-09-23 Liventa Bioscience, Inc. Method of tendon repair with amnion and chorion constructs
WO2012166844A2 (en) 2011-06-01 2012-12-06 Anthrogenesis Corporation Treatment of pain using placental stem cells
EP2785839A2 (en) 2011-11-30 2014-10-08 University of Bremen Expression of mirnas in placental tissue
AU2012358810B2 (en) 2011-12-23 2018-03-15 DePuy Synthes Products, Inc. Detection of human umbilical cord tissue-derived cells
EP2814950A1 (en) 2012-02-13 2014-12-24 Gamida-Cell Ltd. Mesenchymal stem cells conditioned medium and methods of generating and using the same
US8961617B2 (en) 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
JP2016506968A (en) 2013-02-05 2016-03-07 アントフロゲネシス コーポレーション Placenta-derived natural killer cells
EP3019186A4 (en) * 2013-07-12 2017-03-29 Patrick J. Casey Method for the harvesting, processing, and storage of proteins from the mammalian feto-placental unit and use of such proteins in compositions and medical treatment
CN103725643B (en) * 2013-12-30 2015-12-30 厦门大学 A kind of method building tissue engineering comea endothelium
CN103966159B (en) * 2014-02-13 2015-08-05 天津和泽干细胞科技有限公司 Human plactnta Subaerial blue green algae and stem cell bank construction process thereof
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
EP3297694A1 (en) 2015-05-21 2018-03-28 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
CN106566798A (en) * 2016-11-08 2017-04-19 华南生物医药研究院 Method for getting amniotic epithelial stem cells and kit
CN111518747A (en) * 2020-04-30 2020-08-11 成都容医汇生物技术研究院 Method for separating and extracting amniotic stem cells from placenta
US20230201272A1 (en) * 2020-05-08 2023-06-29 Tandem Biotherapeutics, Inc. Cell-based therapies and uses thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD225440A1 (en) * 1984-03-27 1985-07-31 Adw Ddr CELL MEDIUM BREED
EP0333328A2 (en) * 1988-02-17 1989-09-20 Genethics Limited Clinical developments using amniotic cells
US4975365A (en) * 1987-05-12 1990-12-04 The John Hopkins University Assay for measuring DNA cell repair potential
WO1993023528A1 (en) * 1992-05-15 1993-11-25 North Carolina State University Avian embryonic stem cells
JPH0994092A (en) * 1995-07-27 1997-04-08 S R L:Kk Human amniotic cell and gene therapy cell comprising the same
EP0815867A1 (en) * 1996-01-23 1998-01-07 Srl, Inc. Cells for treating dementia
WO1998037903A1 (en) * 1997-02-28 1998-09-03 Tseng Scheffer C G Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US6117676A (en) * 1995-07-27 2000-09-12 Srl, Inc. Transfected human amniotic cells and method for producing a gene product

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD225440A1 (en) * 1984-03-27 1985-07-31 Adw Ddr CELL MEDIUM BREED
US4975365A (en) * 1987-05-12 1990-12-04 The John Hopkins University Assay for measuring DNA cell repair potential
EP0333328A2 (en) * 1988-02-17 1989-09-20 Genethics Limited Clinical developments using amniotic cells
WO1993023528A1 (en) * 1992-05-15 1993-11-25 North Carolina State University Avian embryonic stem cells
JPH0994092A (en) * 1995-07-27 1997-04-08 S R L:Kk Human amniotic cell and gene therapy cell comprising the same
US6117676A (en) * 1995-07-27 2000-09-12 Srl, Inc. Transfected human amniotic cells and method for producing a gene product
EP0815867A1 (en) * 1996-01-23 1998-01-07 Srl, Inc. Cells for treating dementia
WO1998037903A1 (en) * 1997-02-28 1998-09-03 Tseng Scheffer C G Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BURGOS H ET AL: "MAINTENANCE OF HUMAN AMNIOTIC MEMBRANES IN CULTURE", BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, vol. 88, no. 3, 1981, pages 294 - 300, XP000926095, ISSN: 0306-5456 *
DATABASE ncbi 1 January 1900 (1900-01-01), "GRAFT OF CRYOPRESERVED HUMAN AMNIOTIC EPITHELIAL CELLS IN A SUBJECT WITH TYPE B NIEMANN-PICK DISEASE.", XP002154008, Database accession no. 3628058 *
DATABASE WPI Section Ch Week 199724, Derwent World Patents Index; Class B04, AN 1997-266482, XP002154009 *
KRUSE F E ET AL: "CRYOPRESERVED HUMAN AMNIOTIC MEMBRANE FOR OCULAR SURFACE RECONSTRUCTION", GRAEFE'S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY,XX,SPRINGER VERLAG, vol. 238, no. 1, January 2000 (2000-01-01), pages 68 - 75, XP000923120, ISSN: 0721-832X *
TOHYAMA J ET AL: "CHARACTERIZATION OF HUMAN AMNIOTIC EPITHELIAL CELLS TRANSFORMED WITH ORIGIN-DEFECTIVE SV40 T-ANTIGEN GENE", TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE,JP,TOHOKU UNIVERSITY MEDICAL PRESS, SENDAI, vol. 182, 1997, pages 75 - 82, XP000886042, ISSN: 0040-8727 *
UDOH Y ET AL.,: "Long term viability of cryopreserved cultured epithelial grafts", BURNS, vol. 26, no. 6, September 2000 (2000-09-01), pages 535 - 542, XP000926096 *
XUE S ET AL: "Interleukin-1beta Induces the Synthesis and Activity of Cytosolic Phospholipase A2 and the Release of Prostaglandin E2 in Human Amnion-Derived WISH Cells", PROSTAGLANDINS,US,BUTTERWORTH, STONEHAM, MA, vol. 49, no. 6, 1 June 1995 (1995-06-01), pages 351 - 369, XP004032305, ISSN: 0090-6980 *

Cited By (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9149569B2 (en) 2000-12-06 2015-10-06 Anthrogenesis Corporation Treatment of diseases or disorders using placental stem cells
US7976836B2 (en) 2000-12-06 2011-07-12 Anthrogenesis Corporation Treatment of stroke using placental stem cells
US9387283B2 (en) 2000-12-06 2016-07-12 Anthrogenesis Corporation Method of collecting placental stem cells
US7468276B2 (en) 2000-12-06 2008-12-23 Anthrogenesis Corporation Placental stem cells
US7255879B2 (en) 2000-12-06 2007-08-14 Anthrogenesis Corporation Post-partum mammalian placenta, its use and placental stem cells therefrom
US8986984B2 (en) 2000-12-06 2015-03-24 Anthrogenesis Corporation Method of propagating cells
US8580563B2 (en) 2000-12-06 2013-11-12 Anthrogenesis Corporation Placental stem cells
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US8057789B2 (en) 2002-02-13 2011-11-15 Anthrogenesis Corporation Placental stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
US8617535B2 (en) 2002-11-26 2013-12-31 Anthrogenesis Corporation Cytotherapeutics, cytotherapeutic units and methods for treatments using them
US11191789B2 (en) 2003-06-27 2021-12-07 DePuy Synthes Products, Inc. Cartilage and bone repair and regeneration using postpartum-derived cells
US9572840B2 (en) 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US7413734B2 (en) 2003-06-27 2008-08-19 Ethicon, Incorporated Treatment of retinitis pigmentosa with human umbilical cord cells
US8318483B2 (en) 2003-06-27 2012-11-27 Advanced Technologies And Regenerative Medicine, Llc Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US7510873B2 (en) 2003-06-27 2009-03-31 Ethicon, Incorporated Postpartum cells isolated from umbilical cord tissue, and methods of making and using the same
US7560276B2 (en) 2003-06-27 2009-07-14 Ethicon, Incorporated Soft tissue repair and regeneration using postpartum-derived cells
US11179422B2 (en) 2003-06-27 2021-11-23 DePuy Synthes Products, Inc. Method of differentiating umbilical cord tissue into a chondrogenic phenotype
US9504719B2 (en) 2003-06-27 2016-11-29 DePuy Synthes Products, Inc. Soft tissue repair and regeneration using postpartum-derived cells and cell products
US7524489B2 (en) 2003-06-27 2009-04-28 Ethicon Incorporated Regeneration and repair of neural tissue using postpartum-derived cells
US9592258B2 (en) 2003-06-27 2017-03-14 DePuy Synthes Products, Inc. Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
US9498501B2 (en) 2003-06-27 2016-11-22 DePuy Synthes Products, Inc. Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
US7875272B2 (en) 2003-06-27 2011-01-25 Ethicon, Incorporated Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
US9579351B2 (en) 2003-06-27 2017-02-28 DePuy Synthes Products, Inc. Postpartum cells derived from placental tissue, and methods of making and using the same
US9234172B2 (en) 2003-06-27 2016-01-12 DePuy Synthes Products, Inc. Repair and regeneration of ocular tissue using postpartum-derived cells
US8703121B2 (en) 2003-06-27 2014-04-22 DePuy Synthes Products, LLC Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
US8067233B2 (en) 2004-02-26 2011-11-29 Reliance Life Science Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
US8187875B2 (en) 2004-02-26 2012-05-29 Reliance Life Sciences Pvt. Ltd. Dopaminergic neurons derived from corneal limbus, methods of isolation and uses thereof
US7875273B2 (en) 2004-12-23 2011-01-25 Ethicon, Incorporated Treatment of Parkinson's disease and related disorders using postpartum derived cells
US9539288B2 (en) 2005-10-13 2017-01-10 Anthrogenesis Corporation Immunomodulation using placental stem cells
US8895256B2 (en) 2005-10-13 2014-11-25 Anthrogenesis Corporation Immunomodulation using placental stem cells
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US9175261B2 (en) 2005-12-16 2015-11-03 DePuy Synthes Products, Inc. Human umbilical cord tissue cells for inhibiting adverse immune response in histocompatibility-mismatched transplantation
US9125906B2 (en) 2005-12-28 2015-09-08 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US9585918B2 (en) 2005-12-28 2017-03-07 DePuy Synthes Products, Inc. Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
US8691217B2 (en) 2005-12-29 2014-04-08 Anthrogenesis Corporation Placental stem cell populations
US9598669B2 (en) 2005-12-29 2017-03-21 Anthrogenesis Corporation Composition for collecting placental stem cells and methods of using the composition
US8916146B2 (en) 2007-02-12 2014-12-23 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
US8460650B2 (en) 2007-02-12 2013-06-11 Anthrogenesis Corporation Treatment of inflammatory diseases using placental stem cells
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
US9216200B2 (en) 2007-09-28 2015-12-22 Anthrogenesis Corporation Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
US9198938B2 (en) 2008-11-19 2015-12-01 Antrhogenesis Corporation Amnion derived adherent cells
US9121007B2 (en) 2010-01-26 2015-09-01 Anthrogenesis Corporatin Treatment of bone-related cancers using placental stem cells
US9254302B2 (en) 2010-04-07 2016-02-09 Anthrogenesis Corporation Angiogenesis using placental stem cells
US9464274B2 (en) 2010-07-13 2016-10-11 Anthrogenesis Corporation Methods of generating natural killer cells
US8926964B2 (en) 2010-07-13 2015-01-06 Anthrogenesis Corporation Methods of generating natural killer cells
US8969315B2 (en) 2010-12-31 2015-03-03 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules

Also Published As

Publication number Publication date
AU4860900A (en) 2000-12-18
WO2000073421A2 (en) 2000-12-07

Similar Documents

Publication Publication Date Title
WO2000073421A3 (en) Methods of isolation, cryopreservation, and therapeutic use of human amniotic epithelial cells
CA2530416A1 (en) Postpartum cells derived from placental tissue, and methods of making and using the same
WO2002102997A3 (en) Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same
AU2003304250A1 (en) Method of isolating cells from umbilical cord
CA2338541A1 (en) Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy
WO2001036589A3 (en) Human ex vivo immune system
AU2369595A (en) In vitro growth of functional islets of langerhans and in vivo uses thereof
IL210618A (en) Cell cultures comprising isolated expanded human non-embryonic non-germ cells, pharmaceutical compositions comprising the same, methods for their preparation and methods for identifying modulators and differentiation factors
WO2003016507A3 (en) Generation of multipotent central nervous system stem cells
WO2003066072A3 (en) Cell therapy using immunoregulatory t-cells
AR036827A1 (en) KERATINOCITS USED AS A BIOLOGICALLY ACTIVE SUBSTANCE IN WOUND TREATMENT
Labus et al. Expression of Wnt genes in early wound healing
AU2003903896A0 (en) Skin regeneration system
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
ATE400654T1 (en) NEW MAMMAL GENE BC1-W, WHICH BELONGS TO THE BC1-2 FAMILY OF APOPTOSIS-CONTROLING GENES
WO2002098361A3 (en) T cell induced tissue repair and regeneration
EP1499710A4 (en) METHOD FOR THE DEVELOPMENT OF HUMAN CONJUNCTIVE TISSUE EQUIVALENTS FOR RESEARCH, CLINICAL TRANSPLANTATION OF THE OCULAR SURFACE AND TISSUE ENGINEERING
WO2008002283A3 (en) Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism
CN107349220A (en) A kind of preparation comprising fibroblast excretion body and application thereof
WO2001094586A3 (en) Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof
WO2002044355A3 (en) Protozoan expression systems for lysosomal storage disease genes
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
Mirzadegan et al. Application of menstrual blood derived stromal (stem) cells exert greater regenerative potency than fibroblasts/keratinocytes in chronic wounds of diabetic mice
Sheng et al. Make room for dedifferentiation
DE50009932D1 (en) Gene transfer into human lymphocytes using retroviral SCFV cell culture vectors

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP